v3.26.1
Investments and Fair Value Measurements (Tables)
3 Months Ended
Jun. 30, 2026
Fair Value Disclosures [Abstract]  
Schedule of Investments
Our investments related to unconsolidated entities included in other long term assets of the Company’s consolidated balance sheets at June 30, 2026 and March 31, 2026 were:
InvestmentsJune 30,
2026
March 31,
2026
Equity method investments$260 $184 
Other investments192 160 
Total Investments$452 $344 
Schedule of Recurring Fair Value Measurements
The financial instruments measured at fair value on a recurring basis in the accompanying condensed consolidated balance sheets consisted of the following at the periods presented below:
June 30, 2026March 31, 2026
Level 1Level 2TotalLevel 1Level 2Total
Assets:
Money market funds$244 $— $244 $307 $— $307 
Long term deferred compensation plan asset46 — 46 40 — 40 
Total Assets$290 $— $290 $347 $— $347 
Liabilities:
Current derivative instruments$— $$$— $$
Long term deferred compensation plan liability46 — 46 40 — 40 
Total Liabilities$46 $$47 $40 $$41